A Suehiro

Author PubWeight™ 20.30‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Mouse Pitx2 deficiency leads to anomalies of the ventral body wall, heart, extra- and periocular mesoderm and right pulmonary isomerism. Development 1999 2.57
2 Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome. Bone Marrow Transplant 2000 0.95
3 Clinical significance of circulating hepatocyte growth factor, a new risk marker of carotid atherosclerosis in patients with Type 2 diabetes. Diabet Med 2006 0.89
4 Influence of atrial fibrillation on coagulo-fibrinolytic markers in patients with cerebral infarction. Int Angiol 1993 0.88
5 Mechanism of hematuria in glomerular disease. An electron microscopic study in a case of diffuse membranous glomerulonephritis. Nephron 1983 0.87
6 Extracellular pH affects platelet aggregation associated with modulation of store-operated Ca(2+) entry. Thromb Res 2001 0.87
7 Intestinal blood flow at various intraluminal pressures in the piglet with closed abdomen. Ann Surg 1980 0.85
8 [A case of pyogenic granuloma in the sigmoid colon]. Nihon Shokakibyo Gakkai Zasshi 1995 0.84
9 Inhibitory effect of vitamin E (alpha-tocopherol) on spontaneous platelet aggregation in whole blood. Thromb Res 1990 0.83
10 The effects of thoracic aortic cross-clamping and declamping on visceral organ blood flow. Ann Surg 1983 0.82
11 Antiserum to endotoxin in hemorrhagic shock. J Surg Res 1988 0.81
12 Heterogeneous expression of glycoprotein Ib, IX and V in platelets from two patients with Bernard-Soulier syndrome caused by different genetic abnormalities. Thromb Haemost 1995 0.81
13 Regional myocardial blood flow in experimental myocardial infarction after pretreatment with aspirin. J Am Coll Cardiol 1986 0.80
14 Small intestinal blood flow after 48 hours ileus, prostigmin and manual decompression. Z Exp Chir 1980 0.80
15 Oral eicosapentaenoic acid for complications of bone marrow transplantation. Bone Marrow Transplant 2001 0.79
16 Daunorubicin inhibits gene expression of cyclooxygenase-2 in vascular smooth muscle cells. Thromb Res 2001 0.79
17 Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome following allogeneic bone marrow transplantation. Bone Marrow Transplant 2002 0.77
18 The effect of oxygen on the development of atherosclerosis in WHHL rabbits. Atherosclerosis 1983 0.77
19 Does intravenous glutamine prevent bacterial translocation in hemorrhagic shock? Shock 1994 0.76
20 Exogenous nitric oxide inhibits platelet activation in whole blood. J Cardiovasc Pharmacol 1999 0.76
21 Efficacy of the high molecular weight fraction of plasma for the maintenance of pregnancy associated with thrombotic thrombocytopenic purpura. Am J Hematol 1990 0.76
22 Failure of deferoxamine to reduce myocardial infarct size in a primate model of ischemia-reperfusion injury. J Surg Res 1993 0.76
23 Activation of coagulation factor VII by tissue-type plasminogen activator. Am J Hematol 1999 0.76
24 The levels of soluble P-selectin, von Willebrand factor and thrombomodulin in patients with neurological complications after allogeneic bone marrow transplantation. Bone Marrow Transplant 1998 0.75
25 [A paraventricular cyst in congenital cytomegalovirus infection detected by magnetic resonance imaging]. No To Hattatsu 1991 0.75
26 Effect of left ventricular--to--aortic bypass on infarct size and infarct microcirculation in baboons. J Thorac Cardiovasc Surg 1981 0.75
27 LDL receptor activity of cultured arterial smooth muscle cells from genetically hyperlipidemic rabbits (WHHL-rabbit). Kobe J Med Sci 1982 0.75
28 [Anemia and hemostasis dysfunction in patients with immunoproliferative disorders]. Nihon Naika Gakkai Zasshi 1995 0.75
29 [Thrombotic thrombocytopenic purpura: pathophysiology and treatment]. Rinsho Ketsueki 2000 0.75
30 Analysis of intron 13 microsatellite repeat polymorphism of the factor VIII gene by capillary electrophoresis. Semin Thromb Hemost 2000 0.75
31 [A case of Cruveilhier-Baumgarten syndrome. The elucidation of collateral vessels of the portal system by magnetic resonance image]. Nihon Naika Gakkai Zasshi 1988 0.75
32 [A case of refractory thrombocytopenia with a remarkable response to colchicine therapy]. Nihon Naika Gakkai Zasshi 1988 0.75
33 Effects of perfluorocarbon exchange transfusion on reducing myocardial infarct size in a primate model of ischemia-reperfusion injury: a prospective, randomized study. Surgery 1995 0.75
34 Studies of the pathogenesis and management of thrombotic thrombocytopenic purpura. Pol J Pharmacol 1997 0.75
35 Resuscitation from hemorrhagic shock. J Trauma 1983 0.75
36 Counting microaggregate particles in blood. Transfusion 1978 0.75
37 The role of platelet hyperfunction in thrombus formation in hyperlipidemia. Thromb Res 1982 0.75
38 [Management with antithrombin III concentrate in a pregnant woman with hereditary antithrombin III deficiency]. Rinsho Ketsueki 1990 0.75
39 Effect of human thrombocytopenic serum on the cultured endothelial cell growth. Nihon Ketsueki Gakkai Zasshi 1981 0.75
40 Mechanisms of shock blood induced tissue anoxia. Am J Surg 1980 0.75
41 Detection of hydroxyl free radicals in the reperfused primate heart. Free Radic Res 1994 0.75
42 Vasorelaxant effect of trapidil on human basilar artery. J Pharm Pharmacol 1992 0.75
43 A new index for collagen induced platelet aggregation. Thromb Res 1989 0.75
44 [Inhibitory effect of isosorbide dinitrate on whole blood aggregation]. J Cardiol 1997 0.75
45 Differences in platelet aggregation kinetics in normal and hyperlipidemic rabbits. Thromb Res 1985 0.75
46 Platelet trapping in myocardial infarct in baboons: therapeutic effect of aspirin. Am J Cardiol 1980 0.75
47 [Thrombotic thrombocytopenic purpura]. Nihon Naika Gakkai Zasshi 1997 0.75
48 Effects of antitumor agents on inducible prostacyclin production in vascular smooth muscle. Eur J Pharmacol 1999 0.75
49 Clinical significance of new coagulation and fibrinolytic markers in ischemic stroke patients. Stroke 1991 0.75